08.11.2018 Views

Swissmedic Vigilance News Edition 21 – November 2018

In this edition: Isotretinoin and DOAC – Updates Confusion between amphotericin B formulations Guest articles: RPVC Zurich and RPVC Ticino Quality Assurance in Transfusion Practice Statistical Review 2017



In this edition:

Isotretinoin and DOAC – Updates
Confusion between amphotericin B formulations
Guest articles: RPVC Zurich and RPVC Ticino
Quality Assurance in Transfusion Practice
Statistical Review 2017

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Figure 3: Prescriber of quetiapine (Ntot=476)<br />

Conclusion<br />

The results confirm that quetiapine is widely<br />

used in retirement homes in Ticino: A third<br />

of the residents are treated with this medicine.<br />

Quetiapine was administered mainly at<br />

low dosages for an off-label indication, particularly<br />

for the treatment of agitation and<br />

dementia.<br />

A statistically significant link also emerged<br />

between the off-label prescribing of quetiapine<br />

and the prescribing by general practitioners<br />

compared to specialists.<br />

Efforts to raise awareness among general<br />

practitioners about the off-label use of quetiapine<br />

and, possibly, the increased involvement<br />

of specialists in the prescribing of<br />

drugs in retirement homes may help reduce<br />

the frequency of prescription of this drug in<br />

inappropriate cases, and thereby improve<br />

the care of the elderly.<br />

Literature<br />

(1) Alexander GC, Gallagher SA, Mascola A, Moloney<br />

RM, Stafford RS. Increasing off-label use of antipsychotic<br />

medications in the United States, 1995-<br />

2008. Pharmacoepidemiol Drug Saf. 2011<br />

Feb;20(2):177-84<br />

(2) McKean A, Monasterio E. Indications of atypical<br />

antipsychotics in the elderly. Expert Rev Clin Pharmacol.<br />

2015 Jan;8(1):5-7.<br />

(3) McKean A, Monasterio E. Off-label use of atypical<br />

antipsychotics: cause for concern? CNS Drugs.<br />

2012 May 1;26(5):383-90.<br />

(4) Maglione M, Maher AR, Hu J, Wang Z, Shanman<br />

R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, E-<br />

wing BA, Motala A, Perry T. Off-Label Use of Atypical<br />

Antipsychotics: An Update [Internet]. Rockville<br />

(MD): Agency for Healthcare Research and<br />

Quality (US); 2011 Sep.<br />

(5) Brett J. Concerns about quetiapine. Aust Prescr.<br />

2015 Jun;38(3):95-7.<br />

(6) Pharmaceutical Care Research Group (www.imailoffizin.ch),<br />

Les indications off-label de la quétiapine,<br />

2015.<br />

(7) El-Saifi N, Moyle W, Jones C, Tuffaha H. Quetiapine<br />

safety in older adults: a systematic literature<br />

review. J Clin Pharm Ther. 2016 Feb;41(1):7-18.<br />

<strong>Swissmedic</strong> <strong>Vigilance</strong> <strong>News</strong> | <strong>Edition</strong> <strong>21</strong> <strong>–</strong> <strong>November</strong> <strong>2018</strong> 25 | 39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!